Patients in the compassionate use program have to pay for the drug. The Advent rate card is over $200,000 and nowhere is NWBO's revenue's reflect much volume:
2022 $1,683 (000)
2021 $1,005
2020 $1,291
This revenue would represent about a dozen patients paying for compassionate use treatment,
Math and clinical data don't support the Dr. Liau's or your statements.
Market Data 
Markets 
AI
